What is Supernus Pharmaceuticals's restricted cash?

Supernus Pharmaceuticals (SUPN) reported restricted cash of $1.45M in Q1 2026.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Supernus Pharmaceuticals SUPN Restricted Cash

Restricted Cash at other companies

Rapport Therapeutics, Inc.RAPP

$105K0.0%

Acadia PharmaceuticalsACAD

$7.85M-10.5%

Amneal Pharmaceuticals, Inc.AMRX

$4.17M-36.6%

Bausch Health CompaniesBHC

$13M-43.5%

Neurocrine BiosciencesNBIX

——

Praxis Precision Medicines, Inc.PRAX

——

Other financials

Income statement

See full

Revenue$207.7M+38.6%

Gross profit$184.3M+37.5%

Operating income-$8.3M+18.8%

Net income-$2.3M+80.6%

EPS (diluted)-$0.04+81.0%

Balance sheet

See full

Cash & equivalents$186.3M+60.8%

Total debt$40.9M+26.6%

Total equity$1.1B+4.5%

Total assets$1.5B+11.4%

Cash flow

See full

Operating cash flow$66.5M+117%

CapEx--100%

Free cash flow$66.5M+120%

Valuation

See full

Market cap$2.58B+62.8%

Enterprise value$2.44B+62.3%

P/S3.3×+0.9×

Profitability

See full

Gross margin89.4%+1.0pp

Operating margin-7.8%-18.9pp

Net margin-3.7%-13.0pp

FCF margin27.9%+3.4pp

Returns & leverage

See full

Return on equity-2.8%-9.1pp

Debt / equity0×0.0×

Current ratio2×-0.5×

Where this comes from

Reported directly by Supernus Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.

The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Supernus Pharmaceuticals's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Supernus Pharmaceuticals's restricted cash?: Supernus Pharmaceuticals (SUPN) reported restricted cash of $1.45M in Q1 2026.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.